Page last updated: 2024-12-11

zerumbone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

zerumbone: RN given for (E,E,E)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

zerumbone : A sesquiterpenoid and cyclic ketone that is (1E,4E,8E)-alpha-humulene which is substituted by an oxo group at the carbon atom attached to two double bonds. It is obtained by steam distillation from a type of edible ginger, Zingiber zerumbet Smith, grown particularly in southeast Asia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Zingibergenus[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]
Zingiber zerumbetspecies[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]

Cross-References

ID SourceID
PubMed CID5470187
CHEMBL ID245412
CHEBI ID63892
SCHEMBL ID12831266
MeSH IDM0356357

Synonyms (27)

Synonym
nsc698299
nsc-698299
(e,e,e)-2,6,9,9-tetramethyl-2,6,10-cycloundecatrien-1-one
zerumbone
(2e,6e,10e)-2,6,9,9-tetramethylcycloundeca-2,6,10-trien-1-one
471-05-6
2,6,9,9-tetramethylcycloundeca-2,6,10-trien-1-one
bdbm50241296
CHEMBL245412 ,
chebi:63892 ,
C20262
2e,6e,9e-humulatrien-8-one
S5928
SCHEMBL12831266
CCG-208558
HB4130
zerumbone, >=98% (hplc)
Q27132897
CS-0003365
MS-23207
HY-N7015
XZ166948
erumbone
SRCZ-00151
DTXSID601318583
E80606
AKOS040758793

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" This study suggests that the 50% lethal dose (LD50) of ZER-NLC is higher than 200 mg/kg, thus, safe by oral administration."( Acute toxicity study of zerumbone-loaded nanostructured lipid carrier on BALB/c mice model.
Abdul Samad, N; Anasamy, T; Andas, RJ; Chartrand, MS; How, CW; Muhammad Nadzri, N; Namvar, F; Ng, KB; Othman, HH; Rahman, HS; Rasedee, A; Yeap, SK, 2014
)
0.4

Pharmacokinetics

ExcerptReferenceRelevance
"05) in pharmacokinetic parameters of ZER in ZER/HPβCD complex compared with ZER in CMC preparation."( Liquid chromatography-tandem mass spectroscopic method for the determination of zerumbone in human plasma and its application to pharmacokinetics.
Abdul, AB; Eid, EE; Fatah, SA; Rasedee, A; Sukari, MA; Suliman, FE, 2011
)
0.37

Compound-Compound Interactions

ExcerptReferenceRelevance
" Our research aimed to investigate the effect of zerumbone combined with gefitinib in lung cancer."( Zerumbone combined with gefitinib alleviates lung cancer cell growth through the AKT/STAT3/SLC7A11 axis.
Fan, R; Li, DL; Wang, JG; Yan, MJ, 2023
)
0.91

Bioavailability

ExcerptReferenceRelevance
" However, the poor stability, solubility, in vivo bioavailability and weak activity of CU greatly limit its clinical application."( Recent advances of analogues of curcumin for treatment of cancer.
Pi, C; Wei, Y; Ye, Y; Zhao, L; Zhao, S, 2019
)
0.51

Dosage Studied

Syrian golden hamsters were dosed orally with zerumbone (25, 50, and 100 mg/kg) once daily for 8 weeks. Lymphocyte proliferation assay showed that zerUM was able to activate mice thymocytes, splenocytes and PBMC at dosage dependent pattern.

ExcerptRelevanceReference
"05% zerumbone for 5 weeks, starting one week before the first dosing of AOM."( Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet.
Kohno, H; Koshimizu, K; Mori, H; Murakami, A; Ohigashi, H; Safitri, R; Shimizu, M; Takahashi, D; Tanaka, T; Tsukio, Y; Yamamoto, K; Yoshitani, S, 2001
)
0.31
" After being fed HFD for 2 weeks, Syrian golden hamsters were dosed orally with zerumbone (25, 50, and 100 mg/kg) once daily for 8 weeks."( Lipid-lowering effects of zerumbone, a natural cyclic sesquiterpene of Zingiber zerumbet Smith, in high-fat diet-induced hyperlipidemic hamsters.
Chang, CJ; Liou, SS; Liu, IM; Lu, HJ; Tzeng, TF, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
anti-inflammatory agentAny compound that has anti-inflammatory effects.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
glioma-associated oncogene inhibitorAn inhibitor of any of the glioma-associated oncogene (GLI) proteins.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
sesquiterpenoidAny terpenoid derived from a sesquiterpene. The term includes compounds in which the C15 skeleton of the parent sesquiterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
cyclic ketone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
zerumbone biosynthesis110
zerumbone biosynthesis210

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Zinc finger protein GLI1Homo sapiens (human)IC50 (µMol)7.10000.62002.54507.1000AID351770
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)21.80000.00011.753610.0000AID402936
Zinc finger protein GLI2Homo sapiens (human)IC50 (µMol)0.91000.91001.80502.7000AID351771
Cytochrome P450 2D6Homo sapiens (human)IC50 (µMol)100.00000.00002.015110.0000AID402937
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (76)

Processvia Protein(s)Taxonomy
positive regulation of transcription by RNA polymerase IIZinc finger protein GLI1Homo sapiens (human)
osteoblast differentiationZinc finger protein GLI1Homo sapiens (human)
regulation of DNA-templated transcriptionZinc finger protein GLI1Homo sapiens (human)
smoothened signaling pathwayZinc finger protein GLI1Homo sapiens (human)
spermatid developmentZinc finger protein GLI1Homo sapiens (human)
ventral midline developmentZinc finger protein GLI1Homo sapiens (human)
positive regulation of cell population proliferationZinc finger protein GLI1Homo sapiens (human)
regulation of smoothened signaling pathwayZinc finger protein GLI1Homo sapiens (human)
response to woundingZinc finger protein GLI1Homo sapiens (human)
epidermal cell differentiationZinc finger protein GLI1Homo sapiens (human)
dorsal/ventral pattern formationZinc finger protein GLI1Homo sapiens (human)
proximal/distal pattern formationZinc finger protein GLI1Homo sapiens (human)
cerebellar cortex morphogenesisZinc finger protein GLI1Homo sapiens (human)
pituitary gland developmentZinc finger protein GLI1Homo sapiens (human)
lung developmentZinc finger protein GLI1Homo sapiens (human)
prostate gland developmentZinc finger protein GLI1Homo sapiens (human)
regulation of osteoblast differentiationZinc finger protein GLI1Homo sapiens (human)
positive regulation of DNA replicationZinc finger protein GLI1Homo sapiens (human)
positive regulation of smoothened signaling pathwayZinc finger protein GLI1Homo sapiens (human)
positive regulation of DNA-templated transcriptionZinc finger protein GLI1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIZinc finger protein GLI1Homo sapiens (human)
digestive tract morphogenesisZinc finger protein GLI1Homo sapiens (human)
notochord regressionZinc finger protein GLI1Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationZinc finger protein GLI1Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayZinc finger protein GLI1Homo sapiens (human)
liver regenerationZinc finger protein GLI1Homo sapiens (human)
positive regulation of cell cycle G1/S phase transitionZinc finger protein GLI1Homo sapiens (human)
regulation of hepatocyte proliferationZinc finger protein GLI1Homo sapiens (human)
regulation of transcription by RNA polymerase IIZinc finger protein GLI1Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIZinc finger protein GLI2Homo sapiens (human)
skeletal system developmentZinc finger protein GLI2Homo sapiens (human)
kidney developmentZinc finger protein GLI2Homo sapiens (human)
osteoblast developmentZinc finger protein GLI2Homo sapiens (human)
regulation of DNA-templated transcriptionZinc finger protein GLI2Homo sapiens (human)
smoothened signaling pathwayZinc finger protein GLI2Homo sapiens (human)
pattern specification processZinc finger protein GLI2Homo sapiens (human)
axon guidanceZinc finger protein GLI2Homo sapiens (human)
ventral midline developmentZinc finger protein GLI2Homo sapiens (human)
hindgut morphogenesisZinc finger protein GLI2Homo sapiens (human)
heart developmentZinc finger protein GLI2Homo sapiens (human)
proximal/distal pattern formationZinc finger protein GLI2Homo sapiens (human)
floor plate formationZinc finger protein GLI2Homo sapiens (human)
spinal cord dorsal/ventral patterningZinc finger protein GLI2Homo sapiens (human)
ventral spinal cord developmentZinc finger protein GLI2Homo sapiens (human)
cerebellar cortex morphogenesisZinc finger protein GLI2Homo sapiens (human)
smoothened signaling pathway involved in ventral spinal cord interneuron specificationZinc finger protein GLI2Homo sapiens (human)
spinal cord ventral commissure morphogenesisZinc finger protein GLI2Homo sapiens (human)
pituitary gland developmentZinc finger protein GLI2Homo sapiens (human)
lung developmentZinc finger protein GLI2Homo sapiens (human)
mammary gland developmentZinc finger protein GLI2Homo sapiens (human)
hindbrain developmentZinc finger protein GLI2Homo sapiens (human)
hair follicle morphogenesisZinc finger protein GLI2Homo sapiens (human)
positive regulation of T cell differentiation in thymusZinc finger protein GLI2Homo sapiens (human)
tube developmentZinc finger protein GLI2Homo sapiens (human)
odontogenesis of dentin-containing toothZinc finger protein GLI2Homo sapiens (human)
positive regulation of DNA replicationZinc finger protein GLI2Homo sapiens (human)
positive regulation of DNA-templated transcriptionZinc finger protein GLI2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIZinc finger protein GLI2Homo sapiens (human)
embryonic digestive tract developmentZinc finger protein GLI2Homo sapiens (human)
developmental growthZinc finger protein GLI2Homo sapiens (human)
neuron developmentZinc finger protein GLI2Homo sapiens (human)
branching morphogenesis of an epithelial tubeZinc finger protein GLI2Homo sapiens (human)
regulation of transcription by RNA polymerase IIZinc finger protein GLI2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2D6Homo sapiens (human)
steroid metabolic processCytochrome P450 2D6Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2D6Homo sapiens (human)
estrogen metabolic processCytochrome P450 2D6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid catabolic processCytochrome P450 2D6Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2D6Homo sapiens (human)
isoquinoline alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2D6Homo sapiens (human)
retinol metabolic processCytochrome P450 2D6Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of bindingCytochrome P450 2D6Homo sapiens (human)
oxidative demethylationCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular organofluorine metabolic processCytochrome P450 2D6Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 2D6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (38)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingZinc finger protein GLI1Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingZinc finger protein GLI1Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificZinc finger protein GLI1Homo sapiens (human)
DNA bindingZinc finger protein GLI1Homo sapiens (human)
chromatin bindingZinc finger protein GLI1Homo sapiens (human)
protein bindingZinc finger protein GLI1Homo sapiens (human)
microtubule bindingZinc finger protein GLI1Homo sapiens (human)
metal ion bindingZinc finger protein GLI1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificZinc finger protein GLI1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingZinc finger protein GLI1Homo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
DNA-binding transcription factor activityZinc finger protein GLI2Homo sapiens (human)
protein bindingZinc finger protein GLI2Homo sapiens (human)
zinc ion bindingZinc finger protein GLI2Homo sapiens (human)
sequence-specific DNA bindingZinc finger protein GLI2Homo sapiens (human)
sequence-specific double-stranded DNA bindingZinc finger protein GLI2Homo sapiens (human)
promoter-specific chromatin bindingZinc finger protein GLI2Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificZinc finger protein GLI2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingZinc finger protein GLI2Homo sapiens (human)
monooxygenase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activityCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2D6Homo sapiens (human)
heme bindingCytochrome P450 2D6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
cytoplasmZinc finger protein GLI1Homo sapiens (human)
nucleusZinc finger protein GLI1Homo sapiens (human)
nucleoplasmZinc finger protein GLI1Homo sapiens (human)
cytoplasmZinc finger protein GLI1Homo sapiens (human)
cytosolZinc finger protein GLI1Homo sapiens (human)
axonemeZinc finger protein GLI1Homo sapiens (human)
ciliary tipZinc finger protein GLI1Homo sapiens (human)
ciliary baseZinc finger protein GLI1Homo sapiens (human)
GLI-SUFU complexZinc finger protein GLI1Homo sapiens (human)
nucleusZinc finger protein GLI1Homo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
nucleusZinc finger protein GLI2Homo sapiens (human)
nucleoplasmZinc finger protein GLI2Homo sapiens (human)
nucleolusZinc finger protein GLI2Homo sapiens (human)
cytosolZinc finger protein GLI2Homo sapiens (human)
ciliumZinc finger protein GLI2Homo sapiens (human)
ciliary tipZinc finger protein GLI2Homo sapiens (human)
ciliary baseZinc finger protein GLI2Homo sapiens (human)
GLI-SUFU complexZinc finger protein GLI2Homo sapiens (human)
nucleusZinc finger protein GLI2Homo sapiens (human)
mitochondrionCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2D6Homo sapiens (human)
cytoplasmCytochrome P450 2D6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2D6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (45)

Assay IDTitleYearJournalArticle
AID1253864Antiproliferative activity against human HeLa cells2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Synthesis and anti-proliferative activity of novel azazerumbone conjugates with chalcones.
AID511841Cytotoxicity against human KKU-M139 cells at 75 uM2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Cytotoxicity against cholangiocarcinoma cell lines of zerumbone derivatives.
AID1253859Antiproliferative activity against human Lu cells2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Synthesis and anti-proliferative activity of novel azazerumbone conjugates with chalcones.
AID381197Inhibition of 5-lipoxygenase in Wistar rat peritoneal leukocytes at 50 ug/mL1999Journal of natural products, Sep, Volume: 62, Issue:9
Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation.
AID1253861Antiproliferative activity against human MCF7 cells2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Synthesis and anti-proliferative activity of novel azazerumbone conjugates with chalcones.
AID1511042Potentiation of PTX-induced anticancer activity in human DU145 cells assessed as reduction in PTX IC50 (Rvb = 13.5 nmol/L)2019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
AID1384643Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production preincubated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA2018Journal of natural products, 08-24, Volume: 81, Issue:8
Bioactive Sesquiterpenoids from the Peeled Stems of Syringa pinnatifolia.
AID1511033Cytotoxicity against human PC3 cells2019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
AID351771Inhibition of Gli2-mediated transcription expressed in human PANC1 cells2009Journal of medicinal chemistry, Jul-09, Volume: 52, Issue:13
Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
AID1289274Inhibition of FAK signaling pathway in human A549 cells assessed as decrease in OPN-induced FAK phosphorylation at 5 to 10 uM after 15 mins by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID1289268Inhibition of FAK/AKT/ROCK signaling pathway in human A549 cells assessed as decrease in OPN-induced phosphorylation of cofilin at 5 to 10 uM after 24 hrs by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID305648Inhibition of Bacillus subtilis histidine kinase YycG2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Synthesis of a novel inhibitor against MRSA and VRE: preparation from zerumbone ring opening material showing histidine-kinase inhibition.
AID305649Antibacterial activity against methicillin-resistant staphylococcus aureus 870307 after 18 hrs by broth microdilution method2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Synthesis of a novel inhibitor against MRSA and VRE: preparation from zerumbone ring opening material showing histidine-kinase inhibition.
AID1384638Protection against hypoxia-induced injury in mouse H9C2 cells assessed as increase in cell viability at 40 uM incubated for 20 hrs under hypoxia condition by CCK-8 assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
Bioactive Sesquiterpenoids from the Peeled Stems of Syringa pinnatifolia.
AID1384642Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production preincubated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA2018Journal of natural products, 08-24, Volume: 81, Issue:8
Bioactive Sesquiterpenoids from the Peeled Stems of Syringa pinnatifolia.
AID1289263Cytotoxicity against human A549 cells assessed as reduction in cell viability at 20 uM after 24 hrs by MTT assay2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID1289273Effect on total cofilin protein level in OPN-stimulated human A549 cells at 5 to 10 uM after 24 hrs by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID1253862Antiproliferative activity against mouse P338 cells2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Synthesis and anti-proliferative activity of novel azazerumbone conjugates with chalcones.
AID1289275Inhibition of FAK/AKT/ROCK signaling pathway in human A549 cells assessed as decrease in OPN-induced AKT phosphorylation at 5 to 10 uM after 15 mins by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID1289267Anti-invasive activity in human A549 cells assessed as inhibition of OPN-induced cell invasion to matrigel coated invasion chamber at 10 uM preincubated for 30 mins followed by OPN stimulation measured after 24 hrs by boyden chamber assay2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID1289276Effect on total FAK protein level in OPN-stimulated human A549 cells at 5 to 10 uM after 24 hrs by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID1289277Effect on total AKT protein level in OPN-stimulated human A549 cells at 5 to 10 uM after 24 hrs by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID1253863Antiproliferative activity against human SW480 cells2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Synthesis and anti-proliferative activity of novel azazerumbone conjugates with chalcones.
AID1253860Antiproliferative activity against human HepG2 cells2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Synthesis and anti-proliferative activity of novel azazerumbone conjugates with chalcones.
AID1289264Cytotoxicity against human A549 cells assessed as reduction in cell viability at 10 uM after 24 hrs by MTT assay2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID1289272Effect on total LIMK1/2 protein level in OPN-stimulated human A549 cells at 5 to 10 uM after 24 hrs by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID351770Inhibition of Gli1-mediated transcription expressed in human PANC1 cells2009Journal of medicinal chemistry, Jul-09, Volume: 52, Issue:13
Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
AID1384639Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production preincubated for 2 hrs followed by LPS stimulation measured after 24 hrs by Griess reagent based assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
Bioactive Sesquiterpenoids from the Peeled Stems of Syringa pinnatifolia.
AID305650Antibacterial activity against vancomycin-resistant Enterococcus faecalis NCTC-12201 after 18 hrs by broth microdilution method2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Synthesis of a novel inhibitor against MRSA and VRE: preparation from zerumbone ring opening material showing histidine-kinase inhibition.
AID1289270Inhibition of FAK/AKT/ROCK signaling pathway in human A549 cells assessed as decrease in OPN-induced phosphorylation of LIMK1/2 at 5 to 10 uM after 24 hrs by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID402937Inhibition of human CYP2D6 by radiometric assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Sesquiterpenes and flavonol glycosides from Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activities.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1289271Effect on total ROCK1 protein level in OPN-stimulated human A549 cells at 5 to 10 uM after 24 hrs by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID402936Inhibition of human CYP3A4 by radiometric assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Sesquiterpenes and flavonol glycosides from Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activities.
AID381196Inhibition of cyclooxygenase in Wistar rat peritoneal leukocytes at 50 ug/mL1999Journal of natural products, Sep, Volume: 62, Issue:9
Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation.
AID1511030Cytotoxicity against human DU145 cells2019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
AID1289266Anti-invasive activity in human A549 cells assessed as inhibition of OPN-induced cell invasion to matrigel coated invasion chamber at 5 uM preincubated for 30 mins followed by OPN stimulation measured after 24 hrs by boyden chamber assay2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID351772Selectivity ratio of IC50 for Gli1 to IC50 for Gli22009Journal of medicinal chemistry, Jul-09, Volume: 52, Issue:13
Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
AID511842Cytotoxicity against human KKU-M156 cells at 75 uM2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Cytotoxicity against cholangiocarcinoma cell lines of zerumbone derivatives.
AID511840Cytotoxicity against human KKU100 cells at 75 uM2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Cytotoxicity against cholangiocarcinoma cell lines of zerumbone derivatives.
AID1289265Inhibition of FAK/AKT/ROCK signaling pathway in human A549 cells assessed as decrease in OPN-induced lamellipodia formation at 10 uM after 24 hrs by rhodamine phalloidin/DAPI staining based immunofluorescence assay2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
AID511844Cytotoxicity against human KKU-M214 cells at 75 uM2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Cytotoxicity against cholangiocarcinoma cell lines of zerumbone derivatives.
AID511843Cytotoxicity against human KKU-M213 cells at 75 uM2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Cytotoxicity against cholangiocarcinoma cell lines of zerumbone derivatives.
AID1289269Inhibition of FAK/AKT/ROCK signaling pathway in human A549 cells assessed as decrease in OPN-induced ROCK1 expression at 5 to 10 uM after 24 hrs by Western blot analysis2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (192)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (1.04)18.2507
2000's34 (17.71)29.6817
2010's121 (63.02)24.3611
2020's35 (18.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews15 (7.73%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other179 (92.27%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]